Succeeding as a First-time CEO

Authored by Jacob Ambrose Willson, Senior Editor, Criticaleye

Senior Editor Jacob Ambrose Willson talks to members of Criticaleye’s global Community who have taken on the CEO role for the first time and made a success of it, despite facing a unique array of challenges.

Featuring commentary from:

Jon Jayal, CEO, Nexteq
Mark Scanlon, Advisory Board Member, Dittolo and former CEO, Tenet Group
Matthew Blagg, CEO, Criticaleye
Brittany Harris, co-founder and CEO, Qflow
 

Share this with your Community


Contributors
Brittany Harris
Co-founder & CEO
Qualis Flow
Jon Jayal
Former CEO
Nexteq plc
Mark Scanlon
Former CEO
Tenet Group
Matthew Blagg
CEO
Criticaleye


Click here to download this insight

DOWNLOAD INSIGHT



Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.

Click here to download this insight
Driving Growth and Value as C...

Ithaca Energy has developed into a major player in the North Sea oil industry during Iain Lewis’ three years as CFO. In this interview with Criticaleye, he discusses the company’s IPO in 2022, its M&A st...

Click here to download this insight
Embracing the Human-AI Partne...

Singtel faces a rapidly changing environment as geopolitics, customer expectations and AI reshape its business. In discussion with Criticaleye Senior Editor Bridgette Hall, Group Chief People & Sustainability Office...

Click here to download this insight
Reaching New Heights at Guoco...

After four years in the Group CFO role at one of Singapore’s most prominent real estate developers, GuocoLand Group, Andrew Chew talks to Jacob Ambrose Willson about stepping up from regional CFO to Group, managin...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 273




Eightfold AI Aldermore Group AlixPartners London Stock Exchange Group Concentrix Legal & General Rolls-Royce E.ON UK Palo Alto Networks Google NATS Drax Group plc Salesforce Accenture NatWest Group Hitachi Solutions Worldpay Lightsource bp FTSE Women Leaders Review IBM Consulting Workday GlaxoSmithKline plc British Land